Don't hate the stock. Hate your own lack of skill and knowledge. That is the only way to advance in your trading universe. Just my two cents.
SRPT was ready to move, the article just a trigger. Lots of buyer seeing FDA approval soon. This thing will continue to advance long after the article.
F off. YOu clown. You have no stake in this.
Will be 19 by Tuesday.
At first a committee shot it down but was ultimately approved by FDA:
From FDA. Long read:
The U.S. Food and Drug Administration today approved Farydak (panobinostat) for the treatment of patients with multiple myeloma....
In November 2014, the FDA’s Oncologic Drugs Advisory Committee advised the agency that, based on the data reviewed, the drug’s benefits did not outweigh its risks for patients with relapsed multiple myeloma....
Still FDA approved.
Total horse manure. If this is the type of longs I have to play with, then I like it. (hint: market share and how not to lose it.)
Sentiment: Strong Sell
LOL. So smart guy with the "IP tracker". Tell me where I am at.
You thought it did well yesterday, hardly falling after the DOHA fail. You chase it into today. It did get higher. Little did you know that this marks a high point. The coming week, week and a half will be painful.